Polarean Imaging, plc (POLX.L) is a public company, formed from the merger of Polarean, Inc. and m2m. Polarean has developed, manufactures and received FDA approval (Dec. 2022) for XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (“MRI”) for evaluation of lung ventilation.

Redbud Labs is a microfluidics company, with products and technologies that have broad application across a variety of life science segments including basic research, drug discovery and development, biomanufacturing, diagnostics, sequencing and applied markets.

TCG is an international consulting firm that serves medical device, diagnostic, biotech/pharma and other life science companies. The firm provides interim management and strategic transaction advisory services, and maintains offices in the US and Germany.

TEM Systems, Inc. is the US distributor of the ROTEM hemostasis analyzer, providing rapid information about coagulation to better manage bleeding patients. TEM was acquired by Instrumentation Laboratory, a Werfen company.

Curasan is a medical device company that develops and markets regenerative products for dental and orthopedic procedures.

VetInsite is a start-up information technology company providing CRM services to veterinarians and their clients. VetInsite was acquired by MediMedia and was rebranded as "VetStreet".

Biolex is a biotechnology company focused on the production of pharmaceutical proteins by its proprietary Lemna expression system. The company was acquired by Synthon.

Embrex is a agricultural biotechnology company with products for the worldwide commerical poultry industry. The company was acquired by Pfizer / Zoetis.

FMC Corporation is a diversified chemical company with leading positions in industrial chemical markets.